Leadless Pacemakers
Leadless pacemakers provide only single-chamber ventricular pacing and lack defibrillation capacity - Sherrie R. Webb PA-C Print
HWN Suggests
Leadless Pacemakers: Current Achievements and Future Perspectives
Despite the technological advances in pacemaker technology, the transvenous implanted leads are still considered the Achilles’ heel of this rhythm-control therapy. The leadless permanent pacemaker system was developed as an option to bypass the weakness of the transvenous approach. Advances in battery technology and deep miniaturization of electronics now offer the opportunity to implant the whole pacemaker system into the right ventricle.
Featured
The Leadless Pacemaker
The future of leadless device technology is promising and might eventually lead to expanded pacing capabilities.
Articles of Interest
Emerging Technologies in Electrophysiology: From Single-Chamber to Biventricular Leadless Pacemakers
Leadless pacemakers have emerged as a revolutionary innovation to mitigate the complications seen with transvenous pacemakers. Currently, MicraTM TPS or AV with VVI or VDD functionality is the sole leadless pacemakers approved for commercial use worldwide. Although this device has been promising, to date, there have been no randomized trials comparing leadless pacemakers to single chamber transvenous pacemakers.
Leadless pacemakers: a contemporary review
Leadless pacemakers have shown both safety and efficacy in the short term and intermediate follow-up as an alternative to transvenous pacemakers. This technology shows promise in the field of cardiac pacing.

